Tiago C. Felismino

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Transarterial chemoembolization (TACE) with or without immune checkpoint inhibitors in unresectable hepatocellular carcinoma: a meta-analysis of randomized clinical trials.

Transarterial chemoembolization (TACE) with or without immune checkpoint inhibitors in unresectable hepatocellular carcinoma: a meta-analysis of randomized clinical trials.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer.

Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer.

Journal: Journal of gastrointestinal oncology

Published: December 15, 2025

Tumour-Associated Neutrophils in Colorectal Cancer: a Systematic Review, Meta-analysis, and Comprehensive Literature Review.

Tumour-Associated Neutrophils in Colorectal Cancer: a Systematic Review, Meta-analysis, and Comprehensive Literature Review.

Journal: Journal of gastrointestinal cancer

Published: December 07, 2025

Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy.

Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy.

Journal: Journal of gastrointestinal cancer

Published: August 12, 2025

Real-world outcomes of lower lenvatinib doses in advanced neuroendocrine tumors: a multinational retrospective study.

Real-world outcomes of lower lenvatinib doses in advanced neuroendocrine tumors: a multinational retrospective study.

Journal: Endocrine oncology (Bristol, England)

Published: August 06, 2025

Pancreatic neuroendocrine tumors and MUTYH pathogenic variants: a multinational study.

Pancreatic neuroendocrine tumors and MUTYH pathogenic variants: a multinational study.

Journal: Therapeutic advances in medical oncology

Published: March 04, 2025

Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis.

Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis.

Journal: Journal of gastrointestinal oncology

Published: December 03, 2024

Risk factor of severe diarrhea and enterocolitis induced by CAPOX: a retrospective multicenter study.

Risk factor of severe diarrhea and enterocolitis induced by CAPOX: a retrospective multicenter study.

Journal: ESMO gastrointestinal oncology

Published: November 20, 2024

Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review.

Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review.

Journal: Journal of gastrointestinal cancer

Published: November 07, 2024

Influence of biliary and vascular resection types on morbidity in hepatectomies with vascular involvement.

Influence of biliary and vascular resection types on morbidity in hepatectomies with vascular involvement.

Journal: Journal of surgical oncology

Published: April 08, 2024

Dense tumor-infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival.

Dense tumor-infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival.

Journal: Journal of surgical oncology

Published: April 04, 2024

Survival trends in gastric cancer in Brazil: real-life data from a large cancer center.

Survival trends in gastric cancer in Brazil: real-life data from a large cancer center.

Journal: Ecancermedicalscience

Published: December 16, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026